Immuno-oncology Market Grow At Remarkable CAGR 16.5% CAGR with USD 37,783.6 Million by 2028 | Amgen, AstraZeneca Plc, Bristol-Myers Squibb Company, Merck & Co.
One immunotherapy approach is to block the ability of certain proteins, called immune checkpoint proteins, to limit the strength and duration of immune responses
read more..